Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
EBioMedicine (2023) Vol. 95, pp. 104734-104734
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature (2025)
Open Access | Times Cited: 2
The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health
Prakasini Satapathy, Pawan Kumar, Jeetendra Kumar Gupta, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 4, pp. 2498-2501
Open Access | Times Cited: 13
Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes
Achilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses (2024) Vol. 16, Iss. 5, pp. 685-685
Open Access | Times Cited: 9
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections
Dana Unninayar, Emilia Liana Falcone, Hugo Chapdelaine, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Clinical Characteristics During and After COVID‐19 Infection Among Healthcare Workers During the First Wave of Omicron in Chongqing, China
Haoling Tang, Zhiwei Chen, Tianquan Huang, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 1
Open Access
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project
Jiajie Chen, Yuqing Lei, Qiong Wu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status.
Saulesh Kurmangaliyeva, Akzhan M. Madenbayeva, Saltanat T. Urazayeva, et al.
PubMed (2025) Vol. 50, Iss. 2, pp. 61-68
Closed Access
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
Hiam Chemaitelly, Jeremy Samuel Faust, Harlan M. Krumholz, et al.
International Journal of Infectious Diseases (2023) Vol. 136, pp. 81-90
Open Access | Times Cited: 14
Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study
Jingyi Liang, Yangqianxi Wang, Zhijie Lin, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity
Fridah Mwendwa, Akbar Kanji, Ali Raza Bukhari, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 6, pp. 1100-1107
Open Access | Times Cited: 3
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022–May 2023
Ian D. Plumb, Melissa Briggs Hagen, Ryan E. Wiegand, et al.
Vaccine (2023) Vol. 42, Iss. 10, pp. 2543-2552
Open Access | Times Cited: 9
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents
Yasin Abul, Clare Nugent, Igor Vishnepolskiy, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient
Layan Sukik, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Vaccine (2024) Vol. 42, Iss. 14, pp. 3307-3320
Open Access | Times Cited: 2
Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh
Farzana Afroze, Mst. Noorjahan Begum, Tahmeed Ahmed, et al.
Journal of Global Health (2024) Vol. 14
Open Access | Times Cited: 2
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents
Yasin Abul, Clare Nugent, Igor Vishnepolskiy, et al.
GeroScience (2024)
Closed Access | Times Cited: 2
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Jeremy Samuel Faust, et al.
BMJ Public Health (2023) Vol. 1, Iss. 1, pp. e000479-e000479
Open Access | Times Cited: 6
Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients
Shu-Farn Tey, Ya‐Wen Tsai, Jheng‐Yan Wu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Vaccine-elicited immune pressure and SARS-CoV-2 mutational dynamics in breakthrough infections
Sarwareddy Kartik Kumar, Srinivas Sathrasala, Jandhyala Sai Krishna, et al.
Gene Reports (2024) Vol. 35, pp. 101899-101899
Closed Access | Times Cited: 1
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region
Manuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 906-906
Open Access | Times Cited: 1
BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 10
Open Access | Times Cited: 1
Benefits of repeated SARS-CoV-2 vaccination and virus-induced cross-neutralization potential in immunocompromised transplant patients and healthy individuals
David Hauser, Lorena Urda, Christopher Lang, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 10
Open Access
Long-term effectiveness of an ultra-rapid rollout vaccination campaign with BNT162b2 on the incidence of SARS-CoV-2 infection
Lena Tschiderer, Hanna Innerhofer, Lisa Seekircher, et al.
iScience (2024) Vol. 27, Iss. 11, pp. 111117-111117
Closed Access
Preparing for pandemics needs a dose of public health and a booster of “complex thought” (Errare humanum est, perseverare diabolicum)
Élisabeth Paul, Garrett Wallace Brown, David Bell, et al.
Global Policy (2024) Vol. 15, Iss. 5, pp. 969-978
Open Access
Longevity of hybrid immunity against SARS-CoV-2 in adults vaccinated with an adenovirus- based COVID-19 vaccine
Memory Mvula, Fatima Mtonga, Jonathan Mandolo, et al.
Research Square (Research Square) (2024)
Open Access
Understanding Antibody Magnitude and Durability Following Vaccination Against Sars-Cov-2
Quiyana M. Murphy, Mohammad M. Sajadi, Stanca M. Ciupe, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top